We are live on ! Find out more
JGC

J. Goldman & Co Portfolio holdings

AUM $3.44B
1-Year Est. Return 33.8%
This Fund
S&P 500
This Quarter Est. Return
+0.69%
1 Year Est. Return
+33.8%
3 Year Est. Return
+89.45%
5 Year Est. Return
+82.14%
10 Year Est. Return
+407.39%
AUM
$3.53B
AUM Growth
+$430M
Cap. Flow
+$424M
Cap. Flow %
11.99%
Top 10 Hldgs %
19.3%
Holding
632
New
232
Increased
83
Reduced
96
Closed
207

Top Buys

Rank Stock Value
1
STZ icon
Constellation Brands
STZ
+$111M
2
EA icon
Electronic Arts
EA
+$45.7M
3
AKAM icon
Akamai
AKAM
+$45.1M
4
ALIT icon
Alight
ALIT
+$40.9M
5
MRK icon
Merck
MRK
+$39.9M

Top Sells

Rank Stock Value
1
SHW icon
Sherwin-Williams
SHW
+$62.7M
2
BBY icon
Best Buy
BBY
+$59.6M
3
TKO icon
TKO Group
TKO
+$54.5M
4
HAS icon
Hasbro
HAS
+$47.1M
5
NSC icon
Norfolk Southern
NSC
+$46.1M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 16.97%
2 Technology 13.31%
3 Industrials 12.3%
4 Healthcare 9.88%
5 Communication Services 7.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABBV icon
426
PUT
AbbVie
ABBV
$443B
– –
-20,000
Closed -$3.64M
ABEO icon
427
Abeona Therapeutics
ABEO
$366M
– –
-22,750
Closed -$165K
ACIC icon
428
CALL
American Coastal Insurance
ACIC
$515M
– –
-18,800
Closed -$201K
ACN icon
429
Accenture
ACN
$102B
– –
-9,525
Closed -$2.92M
ACVA icon
430
ACV Auctions
ACVA
$1.31B
– –
-24,458
Closed -$459K
ADI icon
431
Analog Devices
ADI
$179B
– –
-62,581
Closed -$12.4M
AFRM icon
432
CALL
Affirm
AFRM
$23.9B
– –
-15,000
Closed -$559K
ALKS icon
433
PUT
Alkermes
ALKS
$8.22B
– –
-13,500
Closed -$365K
ALT icon
434
PUT
Altimmune
ALT
$552M
– –
-27,000
Closed -$275K
AMD icon
435
Advanced Micro Devices
AMD
$776B
– –
-159,615
Closed -$28.8M
AMGN icon
436
PUT
Amgen
AMGN
$208B
– –
-20,000
Closed -$5.69M
AMLX icon
437
CALL
Amylyx Pharmaceuticals
AMLX
$2.26B
– –
-53,900
Closed -$153K
ANNX icon
438
Annexon
ANNX
$834M
– –
-14,670
Closed -$75.9K
APLT
439
DELISTED
Applied Therapeutics
APLT
– –
-146,392
Closed -$693K
APP icon
440
Applovin
APP
$133B
– –
-15,788
Closed -$1.09M
ARGX icon
441
CALL
argenx
ARGX
$53.4B
– –
-8,000
Closed -$3.15M
AROC icon
442
Archrock
AROC
$6.27B
– –
-56,080
Closed -$1.1M
ATKR icon
443
Atkore
ATKR
$2.46B
– –
-40,479
Closed -$7.71M
ATRA icon
444
Atara Biotherapeutics
ATRA
$75.5M
– –
-39,466
Closed -$685K
AZN icon
445
PUT
AstraZeneca
AZN
$263B
– –
-40,000
Closed -$5.42M
BBY icon
446
Best Buy
BBY
$18.2B
– –
-726,585
Closed -$59.6M
BC icon
447
PUT
Brunswick
BC
$5.13B
– –
-321,800
Closed -$31.1M
BE icon
448
CALL
Bloom Energy
BE
$60.6B
– –
-75,000
Closed -$843K
BHC icon
449
CALL
Bausch Health
BHC
$2.57B
– –
-135,000
Closed -$1.43M
BHC icon
450
Bausch Health
BHC
$2.57B
– –
-21,137
Closed -$224K
16 17
18
19 20

Similar funds

CIA
Caledonia Investments (Australia) Sydney NSW, Australia $3.44B AUM 20.03% 1-Year Est. Return
PWP
Perfromance Wealth Partners Hinsdale, Illinois $3.45B AUM 29.14% 1-Year Est. Return
RBA
Richard Bernstein Advisors New York $3.45B AUM 16.24% 1-Year Est. Return
CCM
Check Capital Management Costa Mesa, California $3.44B AUM 9.15% 1-Year Est. Return
PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
LNC
Lincoln National Corp Radnor, Pennsylvania $3.45B AUM 12.55% 1-Year Est. Return
DAM
Davis Asset Management Sausalito, California $3.46B AUM 9.77% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return

J. Goldman & Co's Q2 2024 Portfolio in Review

As of Q2 2024, J. Goldman & Co held 632 positions worth $3.53B, up 14% from $3.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

J. Goldman & Co deployed $424M of net new capital in Q2 2024, opening 232 new positions and adding to 83 existing holdings. Its largest new stake was Constellation Brands: 431,859 shares worth $111M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, down from 18% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Texas Instruments, an estimated $30M trimmed.

  • J. Goldman & Co's largest Q2 2024 buy was Constellation Brands: 431,859 shares worth $111M.
  • J. Goldman & Co added most to Merck in Q2 2024, an estimated $39.9M increase.
  • J. Goldman & Co's biggest Q2 2024 reduction was Texas Instruments, cutting an estimated $30M.
  • J. Goldman & Co fully exited Sherwin-Williams in Q2 2024, selling an estimated $62.7M.
  • J. Goldman & Co's ten largest holdings make up 19% of its $3.53B portfolio in Q2 2024.
  • J. Goldman & Co opened 232 new positions and closed 207 in Q2 2024.
  • J. Goldman & Co's portfolio value rose 14% quarter-over-quarter to $3.53B.

Based on J. Goldman & Co's 13F filing for Q2 2024, filed 14 Aug 2024.